A novel anti-inflammatory mechanism of high density lipoprotein through up-regulating annexin A1 in vascular endothelial cells.
暂无分享,去创建一个
D. Jin | S. Pennathur | Bing Pan | Lemin Zheng | B. Willard | Jian Kong | Jinge Kong | Shuying Dong | Donghui Liu | Dan He | Yubin He | Liang Ji | Jingru Jin | Liming Kong
[1] C. Weber,et al. Annexin A1 counteracts chemokine-induced arterial myeloid cell recruitment. , 2015, Circulation research.
[2] Bernadette A. Thomas,et al. Global, regional, and national age–sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013 , 2015, The Lancet.
[3] J. Frostegård,et al. Induction of Dendritic Cell–Mediated T-Cell Activation by Modified but Not Native Low-Density Lipoprotein in Humans and Inhibition by Annexin A5: Involvement of Heat Shock Proteins , 2015, Arteriosclerosis, thrombosis, and vascular biology.
[4] C. Reutelingsperger,et al. AnxA5 reduces plaque inflammation of advanced atherosclerotic lesions in apoE−/− mice , 2014, Journal of cellular and molecular medicine.
[5] G. Vatcher,et al. Traumatic scratch injury in astrocytes triggers calcium influx to activate the JNK/c‐Jun/AP‐1 pathway and switch on GFAP expression , 2013, Glia.
[6] J. Haeggström,et al. Annexin A5 inhibits atherogenic and pro-inflammatory effects of lysophosphatidylcholine. , 2013, Prostaglandins & other lipid mediators.
[7] G. Dusting,et al. Annexin Peptide Ac2-26 Suppresses TNFα-Induced Inflammatory Responses via Inhibition of Rac1-Dependent NADPH Oxidase in Human Endothelial Cells , 2013, PloS one.
[8] T. Lehtimäki,et al. Smooth muscle cells in human atherosclerosis: proteomic profiling reveals differences in expression of Annexin A1 and mitochondrial proteins in carotid disease. , 2013, Journal of molecular and cellular cardiology.
[9] E. Maggioli,et al. Identification of an essential endogenous regulator of blood–brain barrier integrity, and its pathological and therapeutic implications , 2012, Proceedings of the National Academy of Sciences.
[10] Y. E. Chen,et al. Diabetic HDL Is Dysfunctional in Stimulating Endothelial Cell Migration and Proliferation Due to Down Regulation of SR-BI Expression , 2012, PloS one.
[11] A. Lochner,et al. Endothelial dysfunction: the early predictor of atherosclerosis , 2012, Cardiovascular journal of Africa.
[12] E. Bruckert,et al. LDL-apheresis depletes apoE-HDL and pre-β1-HDL in familial hypercholesterolemia: relevance to atheroprotection , 2011, Journal of Lipid Research.
[13] Y. E. Chen,et al. Human apolipoprotein A-I induces cyclooxygenase-2 expression and prostaglandin I-2 release in endothelial cells through ATP-binding cassette transporter A1. , 2011, American journal of physiology. Cell physiology.
[14] B. Cheuk,et al. Annexin A1 expression in atherosclerotic carotid plaques and its relationship with plaque characteristics. , 2011, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.
[15] T. Lüscher,et al. High-density lipoprotein-mediated anti-atherosclerotic and endothelial-protective effects: a potential novel therapeutic target in cardiovascular disease. , 2010, Current pharmaceutical design.
[16] S. Oliani,et al. Annexin 1 mimetic peptide protects against renal ischemia/reperfusion injury in rats , 2010, Journal of Molecular Medicine.
[17] I. Matsuoka,et al. Mechanism and Role of High Density Lipoprotein-induced Activation of AMP-activated Protein Kinase in Endothelial Cells* , 2009, The Journal of Biological Chemistry.
[18] R. Touyz,et al. Dysregulation of Vascular TRPM7 and Annexin-1 Is Associated With Endothelial Dysfunction in Inherited Hypomagnesemia , 2009, Hypertension.
[19] F. D’Acquisto,et al. Annexin A1 and glucocorticoids as effectors of the resolution of inflammation , 2009, Nature Reviews Immunology.
[20] H. Kurose,et al. Induction of Scavenger Receptor Class B Type I Is Critical for Simvastatin Enhancement of High-Density Lipoprotein-Induced Anti-Inflammatory Actions in Endothelial Cells1 , 2008, The Journal of Immunology.
[21] S. Hammad,et al. High Density Lipoprotein-associated Sphingosine 1-Phosphate Promotes Endothelial Barrier Function* , 2008, Journal of Biological Chemistry.
[22] K. Pritchard,et al. Comparative proteomic analysis of PAI‐1 and TNF‐alpha‐derived endothelial microparticles , 2008, Proteomics.
[23] J. Eng,et al. Proteomics Analysis of Human Coronary Atherosclerotic Plaque , 2007, Molecular & Cellular Proteomics.
[24] D. Rader,et al. High-Density Lipoprotein Promotes Endothelial Cell Migration and Reendothelialization via Scavenger Receptor-B Type I , 2005, Circulation research.
[25] P. Barter,et al. Reconstituted High-Density Lipoproteins Inhibit the Acute Pro-Oxidant and Proinflammatory Vascular Changes Induced by a Periarterial Collar in Normocholesterolemic Rabbits , 2005, Circulation.
[26] T. Sturgill,et al. Glucose Regulates Interleukin-8 Production in Aortic Endothelial Cells through Activation of the p38 Mitogen-activated Protein Kinase Pathway in Diabetes* , 2004, Journal of Biological Chemistry.
[27] R. Ye,et al. Serum amyloid A induces IL-8 secretion through a G protein-coupled receptor, FPRL1/LXA4R. , 2003, Blood.
[28] Amir Lerman,et al. Endothelial Dysfunction: A Marker of Atherosclerotic Risk , 2003, Arteriosclerosis, thrombosis, and vascular biology.
[29] M. Perretti,et al. Annexin 1 Modulates Monocyte-Endothelial Cell Interaction In Vitro and Cell Migration In Vivo in the Human SCID Mouse Transplantation Model1 , 2002, The Journal of Immunology.
[30] H. Christian,et al. Annexin 1-dependent actions of glucocorticoids in the anterior pituitary gland: roles of the N-terminal domain and protein kinase C. , 2002, Endocrinology.
[31] S. Marullo,et al. Annexin 1 Binds to U937 Monocytic Cells and Inhibits Their Adhesion to Microvascular Endothelium: Involvement of the α4β1 Integrin1 , 2000, The Journal of Immunology.
[32] S. Marullo,et al. Annexin 1 binds to U937 monocytic cells and inhibits their adhesion to microvascular endothelium: involvement of the alpha 4 beta 1 integrin. , 2000, Journal of immunology.
[33] W. Erl,et al. Monocyte Arrest and Transmigration on Inflamed Endothelium in Shear Flow Is Inhibited by Adenovirus-Mediated Gene Transfer of IκB- , 1999 .
[34] J. Saklatvala,et al. High-density lipoproteins differentially modulate cytokine-induced expression of E-selectin and cyclooxygenase-2. , 1999, Arteriosclerosis, thrombosis, and vascular biology.
[35] J. Gamble,et al. High-density lipoproteins inhibit cytokine-induced expression of endothelial cell adhesion molecules. , 1995, Arteriosclerosis, thrombosis, and vascular biology.
[36] H. Pollard,et al. Annexins: the problem of assessing the biological role for a gene family of multifunctional calcium- and phospholipid-binding proteins. , 1994, Biochimica et biophysica acta.
[37] A. J. Valente,et al. Monocyte transmigration induced by modification of low density lipoprotein in cocultures of human aortic wall cells is due to induction of monocyte chemotactic protein 1 synthesis and is abolished by high density lipoprotein. , 1991, The Journal of clinical investigation.
[38] G. Striker,et al. Factors influencing endothelial cell proliferation in vitro , 1978, Journal of cellular physiology.